Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR.

J Hepatol. 2013 Apr;58(4):785-91. doi: 10.1016/j.jhep.2012.11.042. Epub 2012 Dec 2.

2.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
3.

Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.

Liu J, Han L, Zhu L, Yu Y.

Lipids Health Dis. 2016 Feb 11;15:27. doi: 10.1186/s12944-016-0194-7.

4.

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.

Vida M, Gavito AL, Pavón FJ, Bautista D, Serrano A, Suarez J, Arrabal S, Decara J, Romero-Cuevas M, Rodríguez de Fonseca F, Baixeras E.

Dis Model Mech. 2015 Jul 1;8(7):721-31. doi: 10.1242/dmm.019166. Epub 2015 May 14.

5.

Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation.

Kim YJ, Choi MS, Park YB, Kim SR, Lee MK, Jung UJ.

World J Gastroenterol. 2013 Aug 7;19(29):4689-701. doi: 10.3748/wjg.v19.i29.4689.

6.

Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.

Kopec AK, Joshi N, Towery KL, Kassel KM, Sullivan BP, Flick MJ, Luyendyk JP.

J Pharmacol Exp Ther. 2014 Nov;351(2):288-97. doi: 10.1124/jpet.114.218545. Epub 2014 Aug 19.

7.

A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice.

Sinha-Hikim I, Sinha-Hikim AP, Shen R, Kim HJ, French SW, Vaziri ND, Crum AC, Rajavashisth TB, Norris KC.

Exp Mol Pathol. 2011 Aug;91(1):419-28. doi: 10.1016/j.yexmp.2011.04.009. Epub 2011 May 3. Erratum in: Exp Mol Pathol. 2012 Oct;93(2):282. Vaziri, Nosratola D [corrected to Vaziri, Nosratola D]; Crum, Albert [corrected to Crum, Albert C]. Exp Mol Pathol. 2012 Oct;93(2):281. Kim, H [corrected to Kim, Hyun Ju].

8.

Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.

Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, Hu B.

Biochem Pharmacol. 2014 Sep 1;91(1):74-86. doi: 10.1016/j.bcp.2014.07.002. Epub 2014 Jul 12.

PMID:
25026599
9.

Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.

Choi S, Choi Y, Choi Y, Kim S, Jang J, Park T.

Food Chem. 2013 Dec 15;141(4):3627-35. doi: 10.1016/j.foodchem.2013.06.028. Epub 2013 Jun 17.

PMID:
23993530
10.

A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.

Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F.

Clin Exp Pharmacol Physiol. 2013 Jul;40(7):422-30. doi: 10.1111/1440-1681.12102.

PMID:
23611112
11.

Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.

Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M.

J Hepatol. 2014 May;60(5):1017-25. doi: 10.1016/j.jhep.2013.12.012. Epub 2013 Dec 19.

PMID:
24362075
12.

miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.

Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM.

J Hepatol. 2013 Jan;58(1):119-25. doi: 10.1016/j.jhep.2012.08.008. Epub 2012 Aug 15.

PMID:
22902550
13.

Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.

Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.

Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G320-7. doi: 10.1152/ajpgi.00181.2013. Epub 2013 Dec 19.

14.

(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.

Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC.

Eur J Pharmacol. 2016 Oct 5;788:200-9. doi: 10.1016/j.ejphar.2016.06.040. Epub 2016 Jun 23.

PMID:
27343380
15.

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.

Monsénégo J, Mansouri A, Akkaoui M, Lenoir V, Esnous C, Fauveau V, Tavernier V, Girard J, Prip-Buus C.

J Hepatol. 2012 Mar;56(3):632-9. doi: 10.1016/j.jhep.2011.10.008. Epub 2011 Oct 25.

PMID:
22037024
16.
17.

The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.

Lin Z, Wu ZF, Jiang CH, Zhang QW, Ouyang S, Che CT, Zhang J, Yin ZQ.

Phytomedicine. 2016 Nov 15;23(12):1475-1483. doi: 10.1016/j.phymed.2016.08.003. Epub 2016 Aug 17.

PMID:
27765368
18.

Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.

Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, Bhatnagar A, McClain CJ, Cave M.

J Nutr Biochem. 2013 Sep;24(9):1587-95. doi: 10.1016/j.jnutbio.2013.01.009. Epub 2013 Apr 22.

19.

The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.

Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, Carreras MC, Poderoso JJ, Gores GJ.

Liver Int. 2015 Mar;35(3):953-66. doi: 10.1111/liv.12570. Epub 2014 Jun 6.

PMID:
24750664
20.

Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.

Pan X, Wang P, Luo J, Wang Z, Song Y, Ye J, Hou X.

Endocrine. 2015 Apr;48(3):834-47. doi: 10.1007/s12020-014-0384-x. Epub 2014 Aug 20.

PMID:
25138963

Supplemental Content

Support Center